Resistin Is a Key Mediator of Glucose-dependent Insulinotropic Polypeptide (GIP) Stimulation of Lipoprotein Lipase (LPL) Activity in Adipocytes
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Studies on the physiological roles of the incretin hormone, glucose-dependent insulinotropic polypeptide (GIP) have largely focused on its insulinotropic action and ability to regulate beta-cell mass. In previous studies on the stimulatory effect of GIP on adipocyte lipoprotein lipase (LPL), a pathway was identified involving increased phosphorylation of protein kinase B (PKB) and reduced phosphorylation of LKB1 and AMP-activated protein kinase (AMPK). The slow time of onset of the responses suggested that GIP may have induced release of an intermediary molecule, and the current studies focused on the possible contribution of the adipokine resistin. In differentiated 3T3-L1 adipocytes, GIP, in the presence of insulin, increased resistin secretion through a pathway involving p38 mitogen-activated protein kinase (p38 MAPK) and the stress-activated protein kinase/Jun amino-terminal kinase (SAPK/JNK). The other major incretin hormone, glucagon-like peptide-1 (GLP-1), exhibited no significant effects. Chronic elevation of circulating GIP levels in the Vancouver Diabetic Fatty (VDF) Zucker rat resulted in increases in circulating resistin levels and activation of p38 MAPK or SAPK/JNK in epididymal fat tissue, suggesting the existence of identical pathways in vivo as well as in vitro. Administration of resistin to 3T3-L1 adipocytes mimicked the effects of GIP on the PKB/LKB1/AMPK/LPL pathway: increasing phosphorylation of PKB, reducing levels of phosphorylated LKB1 and AMPK, and increasing LPL activity. Knockdown of resistin using RNA interference attenuated the effect of GIP on the PKB/LKB1/AMPK/LPL pathway in 3T3-L1 adipocytes, supporting a role for resistin as a mediator.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“GIP promotes lipogenesis and lipid deposition under conditions of hyperinsulinema [34–36] while stimulating lipolysis and fatty acid oxidation under conditions of normo- or hypoinsulinemia [37–39].”
From Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes (2024) · cites this paper as [35]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Inhibition of gastric inhibitory polypeptide signaling prevents obesity
Miyawaki, K., Yamada, Y., Ban, N., Ihara, Y., Tsukiyama, K., Zhou, H., Fujimoto, S., Oku, A., Tsuda, K., Toyokuni, S., et al. (2002) · Nature Medicine · doi:10.1038/nm727 · Cited by 963
Regulation of Fasted Blood Glucose by Resistin
Banerjee, R. R., Rangwala, S. M., Shapiro, J. S., Rich, A. S., Rhoades, B., Qi, Y., Wang, J., Rajala, M. W., Pocai, A., Scherer, P. E., et al. (2004) · Science · doi:10.1126/science.1092341 · Cited by 725
The role of gut hormones in glucose homeostasis
Drucker, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30076 · Cited by 614
A Cysteine-rich Adipose Tissue-specific Secretory Factor Inhibits Adipocyte Differentiation
Kim, K.-H., Lee, K., Moon, Y. S., & Sul, H. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100028200 · Cited by 583
Savage, D. B., Sewter, C. P., Klenk, E. S., Segal, D. G., Vidal-Puig, A., Considine, R. V., & O’Rahilly, S. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2199 · Cited by 572
Research works printed but not linked: 4
- Pederson, R. A., and McIntosh, C. H. S. (2004) in Encyclopedia of Endo- crine Diseases, (Martini, L., ed) Vol. 2, pp. 202-207, Elsevier Inc., New York
- Brown, J. C., Buchan, A. M., McIntosh, C. H. S., and Pederson, R. A. (1989) in Handbook of Physiology (Schultz, S. G., Makhlouf, G. M., and Rauner, B. B., eds) pp. 403-430, American Physiology Society, Bethesda, MD 17.
- Skurk, T., Alberti-Huber, C., Herder, C., and Hauner, H. (2007) Endocri- nology 92, 1023-1033
- Roh, C., Thoidis, G., Farmer, S. R., and Kandror, K. V. (2000) Am. J. Physiol. 279, E893-E899
Cited by
Incretin hormones: Their role in health and disease
Nauck, M. A., & Meier, J. J. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13129 · Cited by 950
The role of incretins in glucose homeostasis and diabetes treatment
Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824
“…AMP-activated protein kinase phosphorylation in differentiated 3T3-L1, cultured subcutaneous human adipocytes, and epidermal fat tissue of the VDF Zucker rat (Kim et al., 2007b) and these effects of GIP are mediated through the direct regulation of adipokine resistin release (Kim et al., 2007c).”
BackgroundResultGIP and GLP-1, the two incretin hormones: Similarities and differences
Seino, Y., Fukushima, M., & Yabe, D. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00022.x · Cited by 746
Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
Finan, B., Ma, T., Ottaway, N., Müller, T. D., Habegger, K. M., Heppner, K. M., Kirchner, H., Holland, J., Hembree, J., Raver, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007218 · Cited by 696
Cardiovascular Biology of the Incretin System
Ussher, J. R., & Drucker, D. J. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1052 · Cited by 530
Cardiovascular Actions of Incretin-Based Therapies
Ussher, J. R., & Drucker, D. J. (2014) · Circulation Research · doi:10.1161/circresaha.114.301958 · Cited by 358
Adipokines and the Peripheral and Neural Control of Energy Balance
Ahima, R. S., & Lazar, M. A. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0529 · Cited by 315
A high-protein diet for reducing body fat: mechanisms and possible caveats
Pesta, D. H., & Samuel, V. T. (2014) · Nutrition & Metabolism · doi:10.1186/1743-7075-11-53 · Cited by 276
“GIP contributes to the regulation of glucose uptake and stimulates triglyceride storage in adipocytes [40].”
Seino, Y., & Yabe, D. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12065 · Cited by 247
The autocrine and paracrine roles of adipokines
Karastergiou, K., & Mohamed-Ali, V. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.11.011 · Cited by 233
“…(Mehebik et al., 2005) (↓) PPARγ (↓) IR kinase activity Activation of NOS Resistin: Metabolic Functions SOCS3 PKB/AMPK 3T3-L1 (Steppan et al., 2005) 3T3-L1 (Kim et al., 2007) (↓) tyrosine phosphorylation of IR (↑) LPL activity TGFβ: Adipogenesis Smad3/4 3T3L1 (Choy et al., 2003) (↓)…”
BackgroundQatanani, M., Szwergold, N. R., Greaves, D. R., Ahima, R. S., & Lazar, M. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37273 · Cited by 230
Anti-obesity therapy: from rainbow pills to polyagonists
Müller, T. D., Clemmensen, C., Finan, B., DiMarchi, R. D., & Tschöp, M. H. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014803 · Cited by 199
“…it stimulates triglyceride release from chylomicrons (Wasada et al., 1981; Ebert et al., 1991), adipocyte glucose and fatty acid uptake (Beck and Max, 1986; Hauner et al., 1988), and adipocyte lipoprotein lipase enzyme activity (Eckel et al., 1979; Knapper et al., 1993; Kim et al., 2007).”
BackgroundKim, S.-J., Nian, C., Karunakaran, S., Clee, S. M., Isales, C. M., & McIntosh, C. H. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040156 · Cited by 182
Self-citationReappraisal of GIP Pharmacology for Metabolic Diseases
Finan, B., Müller, T. D., Clemmensen, C., Perez-Tilve, D., DiMarchi, R. D., & Tschöp, M. H. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.03.005 · Cited by 180
Chapter 15 Glucose‐Dependent Insulinotropic Polypeptide (Gastric Inhibitory Polypeptide; GIP)
McIntosh, C. H. S., Widenmaier, S., & Kim, S. (2009) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)00615-8 · Cited by 171
Self-citationMaternal hormones linking maternal body mass index and dietary intake to birth weight
Jansson, N., Nilsfelt, A., Gellerstedt, M., Wennergren, M., Rossander-Hulthén, L., Powell, T. L., & Jansson, T. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.6.1743 · Cited by 159
Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes
Capozzi, M. E., DiMarchi, R. D., Tschöp, M. H., Finan, B., & Campbell, J. E. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00117 · Cited by 153
Targeting the glucagon receptor family for diabetes and obesity therapy
Cho, Y. M., Merchant, C. E., & Kieffer, T. J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.05.009 · Cited by 158
Kim, S.-J., Nian, C., & McIntosh, C. H. S. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m006841 · Cited by 133
Self-citationPhenotypic flexibility as a measure of health: the optimal nutritional stress response test
Stroeve, J. H. M., van Wietmarschen, H., Kremer, B. H. A., van Ommen, B., & Wopereis, S. (2015) · Genes & Nutrition · doi:10.1007/s12263-015-0459-1 · Cited by 126
“GIP is well known for its role in glucose metabolism by enhancing insulin secretion, but is increasingly considered to be a key modulator of lipid metabolism based on effects found in preclinical and clinical studies (Hansotia et al. 2007; Kim et al. 2007; Gault et al. 2007; McClean et al. 2007).”
BackgroundMusso, G., Cassader, M., De Michieli, F., Rosina, F., Orlandi, F., & Gambino, R. (2012) · Hepatology · doi:10.1002/hep.25739 · Cited by 126
Godinho, R., Mega, C., Teixeira-de-Lemos, E., Carvalho, E., Teixeira, F., Fernandes, R., & Reis, F. (2015) · Journal of Diabetes Research · doi:10.1155/2015/806979 · Cited by 109
“While GLP-1R is expressed in adipocytes [57], activation of GLP-1R affects none of the aforementioned signaling molecules and does not increase LPL activity in adipocytes [58, 59].”
BackgroundMusso, G., Gambino, R., Pacini, G., De Michieli, F., & Cassader, M. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26720 · Cited by 107
Successful weight loss maintenance includes long-term increased meal responses of GLP-1 and PYY3-36
Iepsen, E. W., Lundgren, J., Holst, J. J., Madsbad, S., & Torekov, S. S. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1116 · Cited by 101
Gabe, M. B. N., Sparre‐Ulrich, A. H., Pedersen, M. F., Gasbjerg, L. S., Inoue, A., Bräuner‐Osborne, H., Hartmann, B., & ROSENKILDE, M. M. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.01.040 · Cited by 96
Glucose-dependent insulinotropic polypeptide (GIP)
Müller, T. D., Adriaenssens, A. E., Ahrén, B., Blüher, M., Birkenfeld, A. L., Campbell, J. E., Coghlan, M. P., D’Alessio, D. D., Deacon, C. F., DelPrato, S., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102118 · Cited by 113
Diet: Friend or Foe of Enteroendocrine Cells: How It Interacts with Enteroendocrine Cells
Morán‐Ramos, S., Tovar, A. R., & Torres, N. (2012) · Advances in Nutrition · doi:10.3945/an.111.000976 · Cited by 111
AMPK‐dependent hormonal regulation of whole‐body energy metabolism
Dzamko, N. L., & Steinberg, G. R. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01969.x · Cited by 88
Wei, X., Wang, D., Yang, Y., Xia, M., Li, D., Li, G., Zhu, Y., Xiao, Y., & Ling, W. (2011) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.4275 · Cited by 89
Hutchinson, D. S., Summers, R. J., & Bengtsson, T. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.008 · Cited by 100
Maida, A., Hansotia, T., Longuet, C., Seino, Y., & Drucker, D. J. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.09.004 · Cited by 98
Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease
Musso, G., Gambino, R., & Cassader, M. (2010) · Annual Review of Medicine · doi:10.1146/annurev.med.60.101107.134820 · Cited by 86
Hsieh, Y., Shen, C., Huang, W., Chin, C., Kuo, Y.-H., Hsieh, M. C., Yu, H., Chang, T., Lin, T., Chiu, Y.-W., et al. (2014) · Journal of Biomedical Science · doi:10.1186/1423-0127-21-59 · Cited by 90
GIPR Is Predominantly Localized to Nonadipocyte Cell Types Within White Adipose Tissue
Campbell, J. E., Beaudry, J. L., Svendsen, B., Baggio, L. L., Gordon, A. N., Ussher, J. R., Wong, C. K., Gribble, F. M., D’Alessio, D. A., Reimann, F., et al. (2022) · Diabetes · doi:10.2337/db21-1166 · Cited by 68
Resistin affects lipid metabolism during adipocyte maturation of 3T3‐L1 cells
Ikeda, Y., Tsuchiya, H., Hama, S., Kajimoto, K., & Kogure, K. (2013) · FEBS Journal · doi:10.1111/febs.12514 · Cited by 73
Glucose-dependent insulinotropic polypeptide (GIP) and cardiovascular disease
Heimbürger, S. M., Bergmann, N. C., Augustin, R., Gasbjerg, L. S., Christensen, M. B., & Knop, F. K. (2020) · Peptides · doi:10.1016/j.peptides.2019.170174 · Cited by 67
Pyra, K. A., Saha, D. C., & Reimer, R. A. (2012) · Journal of Nutrition · doi:10.3945/jn.111.147132 · Cited by 73
Siassi, F., Sotoudeh, G., Zolfaghari, H., Askari, G., & Feizi, A. (2016) · International Journal of Preventive Medicine · doi:10.4103/2008-7802.188083 · Cited by 77
“Increase of this polypeptide because of triglyceride accumulation in liver induces NAFLD.[13,14] Table 1: Comparison of demographic, anthropometric, and physical activity data between nonalcoholic fatty liver disease and control groups”
BackgroundWeaver, R. E., Donnelly, D., Wabitsch, M., Grant, P. J., & Balmforth, A. J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.148 · Cited by 63
Møller, C. L., Vistisen, D., Færch, K., Johansen, N. B., Witte, D. R., Jonsson, A., Pedersen, O., Hansen, T., Lauritzen, T., Jørgensen, M. E., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3133 · Cited by 62
Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes
Gutgesell, R. M., Nogueiras, R., Tschöp, M. H., & Müller, T. D. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01566-x · Cited by 61
Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances
Asmar, M., & Holst, J. J. (2010) · Current Opinion in Endocrinology, Diabetes and Obesity · doi:10.1097/med.0b013e3283339051 · Cited by 60
Kwon, E., Lee, J., Kim, Y.-S., Do, A., Choi, J., Cho, S.-J., Jung, U. J., Lee, M., Park, Y., & Choi, M. (2017) · Nutrients · doi:10.3390/nu9060569 · Cited by 65
“Additionally, recent studies demonstrated that the binding of GIP to GIPR in the 3T3-L1 cells and adipose tissue of rats results in the increased secretion of resistin, and thus, GIP activates phosphoinositide 3-kinase (PI3K) and Akt/PKB (protein kinase B) through secreted resistin, thereby suppressing AMP-activated p…”
BackgroundMohammad, S., Ramos, L. S., Buck, J., Levin, L. R., Rubino, F., & McGraw, T. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.289009 · Cited by 59
Kim, S.-J., Nian, C., & McIntosh, C. H. S. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m012203 · Cited by 58
Self-citationGlucose‐dependent insulinotropic polypeptide signaling in pancreatic β‐cells and adipocytes
McIntosh, C. H., Widenmaier, S., & Kim, S. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2012.00196.x · Cited by 57
Self-citationGaal, L. F. V., Gutkin, S. W., & Nauck, M. A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0804 · Cited by 66
Nie, Y., Ma, R. C., Chan, J. C. N., Xu, H., & Xu, G. (2012) · The FASEB Journal · doi:10.1096/fj.11-196782 · Cited by 53
“One possible explanation is the activity of lipoprotein lipase (LPL), an enzyme that hydrolyzes TG to free fatty acid (FFA) for uptake by adipocytes for reesterification and long-term storage of TG, is increased in adipocytes, and this effect is enhanced by GIP in the presence of insulin (18, 19).”
BackgroundUgleholdt, R., Pedersen, J., Bassi, M. R., Füchtbauer, E.-M., Jørgensen, S. M., Kissow, H.-L., Nytofte, N., Poulsen, S. S., Rosenkilde, M. M., Seino, Y., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.311779 · Cited by 49
Li, J., Zheng, J., Wang, S., Lau, H. K., Fathi, A., & Wang, Q. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00015 · Cited by 47
“Moreover, despite limited data on its cardiovascular relevance, GIP receptors have been recognized in the atrial and ventricular tissue of rodents, and activation of these receptors has been linked to lipogenesity (Usdin et al., 1993; Hansotia et al., 2007; Kim et al., 2007).”
BackgroundOu, H., Lee, W., Wu, C.-M., Chen, J. F.-M., & Sheu, W. H. (2012) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.10.011 · Cited by 44
Girard, R., Tremblay, S., Noll, C., St‐Jean, S., Jones, C. M., Gélinas, Y., Maloum-Rami, F., Perreault, N., Laplante, M., Carpentier, A. C., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27934-w · Cited by 48
Bates, H. E., Campbell, J. E., Ussher, J. R., Baggio, L. L., Maida, A., Seino, Y., & Drucker, D. J. (2012) · Diabetes · doi:10.2337/db11-1060 · Cited by 43
“GIP also can stimulate lipogenesis (2,3) and increase the activity of lipoprotein lipase in adipocytes in part through stimulatory effects on resistin secretion (4,5), thus enhancing fatty acid incorporation into adipose tissue.”
BackgroundJørgensen, S. B., Honeyman, J., Oakhill, J. S., Fazakerley, D., Stöckli, J., Kemp, B. E., & Steinberg, G. R. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90744.2008 · Cited by 41
Pleiotropic Actions of the Incretin Hormones
McIntosh, C. H. S., Widenmaier, S. B., & Kim, S. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00002-3 · Cited by 47
Self-citationEffect of 6-gingerol on AMPK- NF-κB axis in high fat diet fed rats
Hashem, R. M., Rashed, L. A., Hassanin, K. M. A., Hetta, M. H., & Ahmed, A. O. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.035 · Cited by 223
“Nutraceuticals treated groups resulted in a substantial decrement in the levels of resistin, additionally, 6- gingerol treatment down regulated the elevated levels of resistin in HFD group more than fish oil treatment, many studies reported that resistin level rise during obesity and promote hyperglycemia and insulin…”
BackgroundGIP’s involvement in the pathophysiology of type 2 diabetes
Christensen, M. B., Gasbjerg, L. S., Heimbürger, S. M., Stensen, S., Vilsbøll, T., & Knop, F. K. (2020) · Peptides · doi:10.1016/j.peptides.2019.170178 · Cited by 35
Derosa, G., Carbone, A., D'Angelo, A., Querci, F., Fogari, E., Cicero, A. F. G., & Maffioli, P. (2013) · Internal Medicine · doi:10.2169/internalmedicine.52.8175 · Cited by 35
“It has recently been shown that binding of glucose-dependent insulinotropic polypeptide (GIP) to GIPR in 3T3-L1 cells and rat epididymal fat results in the enhanced secretion of resistin via a pathway involving p38 MAPK and stress activated protein kinase/Jun aminoterminal kinase [SAPK/JNK (28, 29)].”
BackgroundNovel GLP-1-based Medications for Type 2 Diabetes and Obesity
Son, J. W., le Roux, C. W., Blüher, M., Nauck, M. A., & Lim, S. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnaf036 · Cited by 40
Baldassano, S., Gasbjerg, L. S., Kizilkaya, H. S., ROSENKILDE, M. M., Holst, J. J., & Hartmann, B. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00492 · Cited by 34
Paschetta, E., Hvalryg, M., & Musso, G. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00897.x · Cited by 32
“These findings suggest prolonged GIP elevation impairs b-cell sensitivity to incretin stimulation, possibly by down-regulating b-cell GIP-Rs, and provide a basis for the early b-cell GIP resistance in subjects at increased risk of diabetes (1,83).”
BackgroundDe Block, C. E. M., Dirinck, E., Verhaegen, A., & Van Gaal, L. F. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14640 · Cited by 29
Srinivasan, M., Meadows, M. L., & Maxwell, L. (2018) · Biochemistry Research International · doi:10.1155/2018/7463796 · Cited by 35
“It has been suggested that activation of the adipokine resistin in the islet cells of the pancreas inhibits cell surface glucose transporters and thereby insulin signaling [10, 11].”
BackgroundSub-chronic administration of stable GIP analog in mice decreases serum LPL activity and body weight
Szalowska, E., Meijer, K., Kloosterhuis, N., Razaee, F., Priebe, M. G., & Vonk, R. J. (2011) · Peptides · doi:10.1016/j.peptides.2011.02.011 · Cited by 31
Ohira, M., Miyashita, Y., Murano, T., Watanabe, F., & Shirai, K. (2009) · Metabolism · doi:10.1016/j.metabol.2009.04.024 · Cited by 31
“It is reported that LPL activity in 3T3-L1 adipocytes is increased when AMPK activation is decreased [19,20].”
BackgroundZelicha, H., Yang, J., Henning, S. M., Huang, J., Lee, R., Thames, G., Livingston, E. H., Heber, D., & Li, Z. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.01.008 · Cited by 37
From endocrine to rheumatism: do gut hormones play roles in rheumatoid arthritis?
Chen, C., & Tsai, C. (2013) · Rheumatology · doi:10.1093/rheumatology/ket255 · Cited by 29
Fukuoka, D., Okahara, F., Hashizume, K., Yanagawa, K., Osaki, N., & Shimotoyodome, A. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00268.2014 · Cited by 30
Trošt, Z., Sok, M., Marc, J., & Černe, D. (2009) · Archives of Medical Research · doi:10.1016/j.arcmed.2009.05.001 · Cited by 25
“Finally, resistin synthesized in monocytes and macrophages may also influence tissue LPL activity (27,28).”
BackgroundActivin B inhibits lipolysis in 3T3-L1 adipocytes
Magnusson, B., Svensson, P., Carlsson, L. M. S., & Sjöholm, K. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.022 · Cited by 25
Lotfi, A., Saneei, P., Hekmatdoost, A., Salehi‐Sahlabadi, A., Shiranian, A., & Ghiasvand, R. (2019) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2019.09.004 · Cited by 27
Morrow, N. M., Hanson, A. A., & Mulvihill, E. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.703966 · Cited by 19
Regulation of energy metabolism through central GIPR signaling
Liśkiewicz, A., & Müller, T. D. (2024) · Peptides · doi:10.1016/j.peptides.2024.171198 · Cited by 18
“…when fed with a high-fat diet (HFD) [50], and although GIP promotes lipogenesis in cultured adipocytes under conditions of hyperinsulinemia [39 – 41], it stimulates lipolysis under conditions or normo-or hypoinsulinemia in cultured adipocytes [51,52] and in patients with type 1 diabetes (T1D)…”
Gastrointestinal regulatory peptides and their effects on fat tissue
Majumdar, I. D., & Weber, H. C. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32833327dd · Cited by 18
The role of GIPR in food intake control
James-Okoro, P.-P., Lewis, J. E., Gribble, F. M., & Reimann, F. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1532076 · Cited by 23
Khajavi, N., Biebermann, H., Tschöp, M., & DiMarchi, R. (2017) · Endocrine Development · doi:10.1159/000475737 · Cited by 16
The incretin system and cardiometabolic disease
Szmitko, P. E., Leiter, L. A., & Verma, S. (2010) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(10)70010-6 · Cited by 18
“Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats.”
BackgroundInfluentialKim, S., Nian, C., & McIntosh, C. H. S. (2012) · Diabetes · doi:10.2337/db12-0257 · Cited by 17
“In summary, effects of GIP on PKB/LKB1/AMPK/LPL in Retn+/+ adipocytes were almost completely abolished in Retn+/2 and Retn2/2 adipocytes largely due to greatly reduced GIPR expression, associated with downregulated TNFa signaling and c-Jun–mediated transcriptional activation of the Gipr.”
BackgroundInfluentialSelf-citationImpact of Incretin-Based Therapies on Adipokines and Adiponectin
Yaribeygi, H., Maleki, M., Atkin, S. L., Jamialahmadi, T., & Sahebkar, A. (2021) · Journal of Diabetes Research · doi:10.1155/2021/3331865 · Cited by 19
“Increase resistin and related impacts [68, 75]”
BackgroundThe identification of QTL that affect the fatty acid composition of milk on sheep chromosome 11
García‐Fernández, M., Gutiérrez‐Gil, B., García-Gámez, E., Sánchez, J. P., & Arranz, J. J. (2009) · Animal Genetics · doi:10.1111/j.1365-2052.2009.02000.x · Cited by 15
Naseralallah, L. M. A., & Aboujabal, B. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2181074 · Cited by 18
“GIPR are expressed in adipose tissue, where they directly induce fat accumulation by increasing lipoprotein lipase activity [16].”
BackgroundDipeptidyl peptidase-4 inhibitors in cardioprotection: a promising therapeutic approach
Dai, Y., Dai, D., Mercanti, F., Ding, Z., Wang, X., & Mehta, J. L. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0496-4 · Cited by 13
“GIP, another component of incretins, is known to decrease adipogenesis and enhance adipokine expression [27].”
BackgroundWang, T., Ma, X., Tang, T., Higuchi, K., Peng, D., Zhang, R., Chen, M., Yan, J. Y., Wang, S., Yan, D., et al. (2017) · Nutrition and Diabetes · doi:10.1038/nutd.2017.28 · Cited by 15
Pharmacological Advances in Incretin-Based Polyagonism: What We Know and What We Don’t
Novikoff, A., & Müller, T. D. (2024) · Physiology · doi:10.1152/physiol.00032.2023 · Cited by 15
Tian, J. ‐., Wang, Y., Lin, N., Guo, Y., Sun, S., & Zou, D.-C. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02400.x · Cited by 12
Lee, T., Chen, W.-T., & Chang, N. (2016) · Bioscience Reports · doi:10.1042/bsr20150139 · Cited by 11
Characterization of lipoprotein lipase storage vesicles in 3T3-L1 adipocytes
Roberts, B. S., Yang, C. Q., & Neher, S. B. (2021) · Journal of Cell Science · doi:10.1242/jcs.258734 · Cited by 14
Lee, S., Chung, M. J., Ahn, M., Park, H. J., Wang, E. K., Guon, T., Kee, H. J., Ku, C. R., & Na, K. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122336 · Cited by 9
Belobrajdic, D. P., Jenkins, C. L. D., Christophersen, C. T., & Bird, A. R. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1830-y · Cited by 9
Yang, Z., Zhao, J., Li, J., Wang, J., & Wang, W. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112230 · Cited by 8
Sugunan, D., Nair, A. K., Kumar, H., & Gopalakrishnapillai, A. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-118 · Cited by 8
“GIP has also been shown to play an important role in fat metabolism related diseases like non-alcoholic fatty liver disease (NAFLD) and due to its important role in cholesterol metabolism, an altered expression or function of GIP may play a role in the pathogenesis of cardiovascular diseases as well [36,37].”
BackgroundHirayama, S., Ito, T., Miyazaki, O., Kamimura, T., Hanyu, O., Seino, U., Ito, S., Aizawa, Y., & Miida, T. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.11.010 · Cited by 7
Yang, G., Liang, X., Qin, C., Yang, L., Zhang, Y., Lu, R., Yan, X., Meng, X., & Nie, G. (2021) · Aquaculture · doi:10.1016/j.aquaculture.2021.737682 · Cited by 6
The GIPR is Predominantly Localized to Non-Adipocyte Cell Types Within White Adipose Tissue
Campbell, J. E., Beaudry, J. L., Svendsen, B., Baggio, L. L., Gordon, A. N., Ussher, J. R., Wong, C. K., Gribble, F. M., D’Alessio, D. A., Reimann, F., et al. (2022) · doi:10.2337/figshare.19184462 · Cited by 6
Basic and clinical aspects of resistin
Rosso, C., Caviglia, G. P., Fagoonee, S., Bugianesi, E., & Saracco, G. M. (2018) · Minerva Biotecnologica · doi:10.23736/s1120-4826.18.02404-7 · Cited by 7
Zhang, Z., Shannon, J., & Zhang, H. (2016) · Energy balance and cancer · doi:10.1007/978-3-319-41677-9_9 · Cited by 5
Visfatin and resistin: Mediators of the pleiotropic effects of incretins?
Nakashima, E. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2012.00235.x · Cited by 3
“Kim et al.(2) previously reported that in 3T3-L1 adipocytes, glucose-dependent insulinotropic polypeptide (GIP), in the presence of insulin, increased resistin secretion through a pathway involving p38 mitogen-activated protein kinase (p38 MAPK) and the stress-activated protein kinase/jun amino-terminal kinase (SAPK/J…”
BackgroundYan, X., Jin, W., Zhang, J., Wang, M., Liu, S., & Xin, Y. (2020) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00071 · Cited by 5
“to exacerbate liver steatosis and increase the levels of postprandial resistin and free fatty acids.(16,17) Besides, some evidence has suggested that TCF7L2 rs7903146 is associated with serum lipid indexes, including TG, total cholesterol (TC), LDL, and apolipoprotein B, all of which are associated with risk of CAD de…”
BackgroundOrtiz-Fraguada, M. Y., & Relling, A. E. (2022) · Translational Animal Science · doi:10.1093/tas/txac089 · Cited by 3
“Pre-feeding greater plasma NEFA concentration could be explained based on the need for energy; NEFA are released into circulation from the adipose tissue to meet the metabolic needs of the animals (Bowden, 1971; De Koster and Opsomer, 2013).”
BackgroundDas, S., Ravi, H., Babu, A., Banerjee, M., Ramasubbu, K., Sivaraman, D., Rajeswari, V. D., Venkatraman, G., & Ramanathan, G. (2024) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.12.017 · Cited by 1
Metadata
- Authors
- Kim, S.-J., Nian, C., & McIntosh, C. H. S.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- McIntosh, Christopher H.S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 282
- Issue
- 47
- Pages
- 34139-34147
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2057235055
- Cited by
- 118
- References
- 55
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 5 · 2021: 6 · 2020: 1 · 2019: 4 · 2018: 8 · 2017: 5 · 2016: 5 · 2015: 3 · 2014: 4 · 2013: 8 · 2012: 12
- FWCI
- 7.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4708 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- resistin, glucose-dependent insulinotropic polypeptide, lipoprotein lipase, adipocytes, p38 MAPK, SAPK/JNK, Akt, LKB1, AMPK, incretins, glucagon-like peptide-1, 3T3-L1 adipocytes, adipokines, insulin signaling, epididymal adipose tissue
- MeSH terms
- AMP-Activated Protein Kinase Kinases, Animals, Enzyme Activation, Epididymis, Gastric Inhibitory Polypeptide, Insulin, Lipoprotein Lipase, Male, Multienzyme Complexes, Rats, Zucker, Second Messenger Systems, 3T3 Cells, Protein Serine-Threonine Kinases, Adipocytes, MAP Kinase Signaling System, RNA Interference, p38 Mitogen-Activated Protein Kinases, MAP Kinase Kinase 4, Insulin-Secreting Cells, Proto-Oncogene Proteins c-akt, Mice, Rats, Glucagon-Like Peptide 1, Resistin, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.